- Q1 2024 Allogene Therapeutics Inc Earnings Call TranscriptMay 13, 2024$2.9 (+5.07%)Earnings
- Q4 2023 Allogene Therapeutics Inc Earnings Call TranscriptMar 14, 2024$4.5 (-7.89%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Allogene Therapeutics Inc Platform Vision Call TranscriptJan 04, 2024
- Q3 2023 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2023$2.97 (+4.95%)Earnings
- Q2 2023 Allogene Therapeutics Inc Earnings Call TranscriptAug 02, 2023$4.69 (-2.09%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Allogene Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Allogene Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Allogene Therapeutics Inc Earnings Call TranscriptMay 03, 2023$5.72 (+6.92%)Earnings
- Q4 2022 Allogene Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$6.35 (+0.32%)Earnings
- Allogene Therapeutics Inc at B Riley Securities Oncology Conference (Virtual) TranscriptJan 18, 2023
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Allogene Therapeutics Inc R&D Showcase TranscriptNov 29, 2022
- Allogene Therapeutics Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Q3 2022 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2022$10.17 (-3.78%)Earnings
- Q2 2022 Allogene Therapeutics Inc Earnings Call TranscriptAug 09, 2022$15.03 (-5.83%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Allogene Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Allogene Therapeutics Inc Earnings Call TranscriptMay 04, 2022$9.43 (+4.31%)Earnings
- Q4 2021 Allogene Therapeutics Inc Earnings Call TranscriptFeb 23, 2022$9.17 (-5.66%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Allogene Therapeutics Inc Business Update Call TranscriptJan 10, 2022
- Allogene Therapeutics Inc to Review ALPHA, ALPHA2 and UNIVERSAL Phase 1 Data Presented at the American Society of Hematology Annual Meeting TranscriptDec 13, 2021
- Q3 2021 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2021$19.43 (-3.62%)Earnings
- Allogene Therapeutics Inc Business Update- Conference Call TranscriptOct 07, 2021
- Q2 2021 Allogene Therapeutics Inc Earnings Call TranscriptAug 04, 2021$22.13 (+0.91%)Earnings
- Allogene Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Allogene Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Allogene Therapeutics Inc to Host Virtual CD19 Forum TranscriptMay 19, 2021
- Q1 2021 Allogene Therapeutics Inc Earnings Call TranscriptMay 05, 2021$28.71 (-2.31%)Earnings
- Q4 2020 Allogene Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$32.79 (-4.79%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Allogene Therapeutics Inc to Review The Potential Innovation of Allogeneic CAR T Therapy in Multiple Myeloma TranscriptDec 05, 2020
- Q3 2020 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2020$31.06 (-8.08%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Allogene Therapeutics Inc Earnings Call TranscriptAug 05, 2020$38.45 (+3.69%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 05, 2020
- Q1 2020 Allogene Therapeutics Inc Earnings Call TranscriptMay 06, 2020$30.07 (-2.56%)Earnings
- Q4 2019 Allogene Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$25.92 (+1.85%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Allogene Therapeutics Inc Earnings Call TranscriptNov 05, 2019$27.66 (-4.36%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Allogene Therapeutics Inc Earnings Call TranscriptAug 07, 2019$29.59 (-0.54%)Earnings
- Q1 2019 Allogene Therapeutics Inc Earnings Call TranscriptMay 07, 2019$29.79 (-4.18%)Earnings
- Q4 2018 Allogene Therapeutics Inc Earnings Call TranscriptMar 08, 2019$28.38 (-4.28%)Earnings
Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. We're pleased to have Allogene with us here this morning. And with us, we have David Chang, President and CEO.
Questions & Answers
David, you recently presented initial data from the Phase I ALLO-501 study, your allogeneic CAR T at ASCO this year. Could you start by briefly recapping these findings and help put into context for us, how we should think about these results compared to the early autologous CAR T data?
Yes, Salveen, it's a pleasure to be invited to this conference. And too bad that we have to hold this as a virtual conference. I mean, I always love to go down to the Goldman Sachs conference at a wonderful time in June in Southern California, but such is the life nowadays. So we have
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)